![]() “fter careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks.” The agency said that it would work with Congress to develop a new cross-agency regulatory framework for the substance. “We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” FDA principal deputy commissioner Janet Woodcock said in a statement. Essentially, the FDA has said that CBD is a headache that it doesn’t want to deal with, so it’s kicking things over to Congress to sort out the mess. Further, it expressed concerns that CBD products could be dangerous, especially with long-term use. The FDA announced that it was denying three citizen petitions requesting guidance on CBD the agency’s existing safety standards for supplements or food additives, it ruled, aren’t sufficient to regulate CBD’s use. In late January, the agency finally issued a decision on CBD, and it’s a potentially damning blow to the industry. Without regulation, however, there’s no way for a consumer to know what, exactly, is in that CBD they bought at the gas station - or if it contains any CBD at all. The FDA has warned companies selling CBD products and consumers about unproven health claims made by manufacturers, steadfastly holding that CBD doesn’t meet the definition of a dietary supplement - a position that has been challenged by the industry and consumers as demand for CBD has boomed. So store shelves proliferated with quasi-legal tinctures and gummies and beverages, all taking advantage of the FDA gray area. Food and drinks that contain CBD have never actually been FDA-approved.įor years, the FDA hasn’t come down one way or another with guidance on how to regulate, label, or market CBD in supplements and food products. Any substance marketed as a supplement or food additive has to meet safety standards issued by the Food and Drug Administration, and that’s where things have gotten hairy for CBD manufacturers and marketers. It’s a Wild West time if you’re a hemp entrepreneur.īut CBD, a cannabis compound also known as cannabidiol, exists in a gray area under federal law, and its exact legality has long been tricky to define. Toothpicks? Yep! You can even buy a CBD pillow and bedsheets to infuse your sleep experience with maximum chill. ![]() The anxiety drug du jour seems to have found its way into every kind of lifestyle and household product imaginable. You can shop online and order everything from CBD bath bombs to dog treats you can drink Goop-approved CBD cocktails or nosh on infused candy and cookies. Today, you can buy CBD oil, vapes, tinctures, and edibles in convenience stores, gas stations, and smoke shops from Florida to Oregon. US sales reached $4.17 billion in 2022, and forecasts predicted that the market could quadruple by 2026. But CBD’s rise in popularity - which began exploding in 2019 due to a confluence of consumer trends, including a boom in herbal supplements and the spread of marijuana legalization - was bolstered by the coronavirus pandemic as people sought out ways to alleviate the unique stresses of recent years. The limited research into the medical benefits and risks of CBD doesn’t support most of these cure-all assertions. Over the past few years, CBD has rocketed to the forefront of the wellness industry, touted as a magical elixir that can treat all sorts of maladies, including pain, anxiety, stress, sleep disorders, diabetes, acne, depression, and even, according to some particularly bold claims, cancer.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |